Minerva Neurosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Minerva Neurosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Minerva Neurosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $96.9M, a 7.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $96.9M +$6.76M +7.5% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $90.1M +$8.76M +10.8% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $81.4M +$10.3M +14.5% Dec 31, 2021 10-K 2023-03-08
Q4 2020 $71M -$1.3M -1.79% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $72.3M +$17.6M +32.2% Dec 31, 2019 10-K 2021-03-08
Q4 2018 $54.7M +$12.8M +30.6% Dec 31, 2018 10-K 2020-03-09
Q4 2017 $41.9M -$9.89M -19.1% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $51.8M +$11.9M +29.8% Dec 31, 2016 10-K 2018-03-12
Q4 2015 $39.9M +$10.3M +34.9% Dec 31, 2015 10-K 2017-03-13
Q4 2014 $29.5M +$20.7M +235% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $8.82M Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.